Latest by Treatment Action Group
One of the more futuristic-sounding ideas for curing HIV involves removing the genome of the virus from the genome of the cells into which it has integrated. On paper, the idea is very appealing, but there are a multitude of challenges.
Table of Contents Credits Acknowledgements Dedication Foreword Volume I: Clinical Science Executive Summary Introduction I. Epidemiology of Hepatitis C II. Natural History of Hepatitis C III. Natural History of HCV in HIV Coinf...
Hepatitis C treatment is changing quickly. Although Olysio (simeprevir) was approved for use with pegylated interferon (PEG-IFN) and ribavirin (RBV), it is being studied and used with other drugs in interferon-free combinations.
Commonly known as a "booster," adding ribavirin to other drugs can increase the chance of being cured from hepatitis C.
Adherence means sticking to something. It is often used to describe taking medicine without missing doses for as long as needed. Good adherence helps to maintain -- or improve -- your health.
The FDA-approved drug disulfiram (Antabuse) may be able to awaken hidden HIV -- in a small, but significant way -- according to results of a clinical trial in 30 HIV-positive individuals on antiretroviral therapy.
Now that hepatitis (HCV) treatment is simpler, safer and more effective, diagnostics need to become simpler and less expensive. Ideally, HCV will soon be diagnosed with a single rapid point-of-care test and cured with a regimen that works for everyon...
Around the globe, for the majority of people who need or desire PrEP (pre-exposure prophylaxis) as part of a complete prevention package, the medication is not affordable without regulatory approval and inclusion in national health programs.
When encountering terms such as remission, functional cure and post-treatment control -- which all too frequently have been used interchangeably -- it's important to appreciate that there remains a lack of consensus as to how exactly to define them, ...
Three recent studies describe a new strategy for attacking the hidden HIV reservoir by engineering antibodies or antibody-like molecules which are capable of binding two targets at the same time.